Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma

Leukemia

Volumn 10, Issue 2, 1996, Pages 346-350

  Tirier, C ^a,c   Zhang, Y ^b   Plendl, H ^b   Weber Matthiesen, K ^b   Langer, W ^a   Heit, W ^a   Schlegelberger, B ^b  

^a Department of Hematology/Oncology   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Evangelic Hospital   (Germany)

Author keywords

Lymphoma with translocation t(11; 14) and t(2; 8); Prognosis

Indexed keywords

ADULT; ARTICLE; BLAST TRANSFORMATION; BURKITT LYMPHOMA; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 11; DISEASE COURSE; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOMA; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0029879818     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Heim S, Mitelman F. Cancer Cytogenetics, 2nd edn. Alan R Liss: New York, 1987.
2. Sahar E, Latt SA. Enhancement of banding pattern in human metaphase chromosomes by energy transfer. Proc Natl Acad Sci USA 1978; 15: 5650-5654.
3. Weber-Matthiesen K, Deerberg J, Muller-Hermelink A, Winkermann M, Schlegelberger B, Grote W. Rationalization of in situ hybridization: testing up to 16 different probes on a single slide. Cancer Genet Cytogenet 1993; 68: 91-94.
4. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowel PC, Croce CM. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224. 1403-1406.
5. Meeker TC, Grimaldi JC, O'Rourke R, Louie E, Juliusson G, Einhorn S An additional breakpoint region in the BCL-1 locus associated with the t(11;14)(q13;q32) translocation of B-lymphocytic malignancy. Blood 1989; 74: 1801-1806.
6. Meeker TC, Sellers W, Harvey R, Withers D, Carey K, Xiao H, Block AM, Dadey B, Han T. Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines. Leukemia 1991; 5: 733-737
7. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a BCL-1 linked candidate oncogene. Nature 1991; 350: 512-515
8. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 7: 1871-1875.
9. Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood 1987; 69: 1617-1621
10. Leroux D, Le Marc'Hadour F, Gressin R, Jacob MC, Keddari E, Monteil M, Caillot P, Jalbert P, Sotto JJ Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol 1991; 77: 346-353.
11. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke RA. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic and molecular data. Am J Surg Pathol 1992; 16: 637-640.
12. Zucca E, Stein H, Coiffier B. European lymphoma task force (ELTF)report of the workshop on mantle cell lymphoma. Ann Oncol 1994; 5: 507-511.
13. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A. PRAD1, a candidate BCL-1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991; 88: 9638-9642.
14. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/Cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993; 7: 241-245.
15. Rabbitts TH. Translocations, master genes and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641-644.
16. Graham M, Adams JM. Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J 1986; 5: 2945-2851.
17. Polack A, Strobl L, Feederle R, Schweizer M, Koch E, Eick D, Wiegand H, Bornkamm GW. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift. Oncogene 1991; 6: 2033-2040.
18. Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gajl-Peczalska KJ. Nonrandom chromosome abnormalities in lymphoma. Cancer Res 1983; 43: 2975-2984.
19. Kaneko Y, Rowley JD, Variakojis D, Haren JM, Ueshima Y, Daly K, Kluskens LF. Prognostic implications of karyotype and morphology in patients with non-Hodgkin's lymphoma. Int J Cancer 1983; 32: 683-692.
20. Polack C, Hagemeijer A. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1987; 1: 541-548.
21. Lee TJ, Innes DJ, Williams ME. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest 1989; 84: 1454-1459.
22. Hecht F, Morgan R, Hecht BK. Unexpected lambda chain expression in lymphocytic malignancy. Int J Radiat Oncol Biol Phys 1985; 11: 267-270.
23. Geisler C, Philip P, Plesner T, Andersson P, Zeuthen J, Guldhammer B, Hansen MM. Simultaneous presence of translocations t(14;18) and t(2;8) in a case of chronic lymphocytic leukemia. Cancer Genet Cytogenet 1986; 22: 35-44.